Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Saved in:
| Title: | Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. |
|---|---|
| Authors: | Shah BD; Moffitt Cancer Center, Tampa, FL, USA. bijal.shah@moffitt.org., Cassaday RD; University of Washington & Fred Hutchinson Cancer Center, Seattle, WA, USA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Houot R; CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France., Logan AC; UCSF Medical Center, San Francisco, CA, USA., Boissel N; Hôpital Saint-Louis, Paris, France., Leguay T; Service d'hématologie clinique et thérapie cellulaire Hopital du Haut-Lévêque CHU de Bordeaux, Bordeaux, France., Bishop MR; The University of Chicago Medicine, Chicago, IL, USA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., O'Dwyer KM; University of Rochester Medical Center, Rochester, NY, USA., Tzachanis D; University of California San Diego, San Diego, CA, USA., Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Baer MR; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Subklewe M; Ludwig-Maximilians-Universität München, München, Germany., Abedi M; University of California Davis Comprehensive Cancer Center Sacramento, Davis, CA, USA., Minnema MC; UMC Utrecht Cancer Center, MS Hematologie, University Medical Center Utrecht, on behalf of HOVON/LLPC, Utrecht, Netherlands., Wierda WG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA., Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Jeyakumar D; University of California Irvine Medical Center, Orange, CA, USA., Mao D; Kite, a Gilead Company, Santa Monica, CA, USA., Adhikary S; Kite, a Gilead Company, Santa Monica, CA, USA., Zhou L; Kite, a Gilead Company, Santa Monica, CA, USA., Hadjivassileva T; Kite, a Gilead Company, Santa Monica, CA, USA., Damico Khalid R; Kite, a Gilead Company, Santa Monica, CA, USA., Ghobadi A; Washington University School of Medicine, St Louis, MO, USA., Oluwole OO; Vanderbilt University Cancer Center, Nashville, TN, USA. |
| Source: | Leukemia [Leukemia] 2025 May; Vol. 39 (5), pp. 1058-1068. Date of Electronic Publication: 2025 Mar 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40108332 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shah+BD%22">Shah BD</searchLink>; Moffitt Cancer Center, Tampa, FL, USA. bijal.shah@moffitt.org.<br /><searchLink fieldCode="AU" term="%22Cassaday+RD%22">Cassaday RD</searchLink>; University of Washington & Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Park+JH%22">Park JH</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Logan+AC%22">Logan AC</searchLink>; UCSF Medical Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Boissel+N%22">Boissel N</searchLink>; Hôpital Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Leguay+T%22">Leguay T</searchLink>; Service d'hématologie clinique et thérapie cellulaire Hopital du Haut-Lévêque CHU de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bishop+MR%22">Bishop MR</searchLink>; The University of Chicago Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Topp+MS%22">Topp MS</searchLink>; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22O'Dwyer+KM%22">O'Dwyer KM</searchLink>; University of Rochester Medical Center, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tzachanis+D%22">Tzachanis D</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Arellano+ML%22">Arellano ML</searchLink>; Winship Cancer Institute of Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Baer+MR%22">Baer MR</searchLink>; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Schiller+GJ%22">Schiller GJ</searchLink>; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Subklewe+M%22">Subklewe M</searchLink>; Ludwig-Maximilians-Universität München, München, Germany.<br /><searchLink fieldCode="AU" term="%22Abedi+M%22">Abedi M</searchLink>; University of California Davis Comprehensive Cancer Center Sacramento, Davis, CA, USA.<br /><searchLink fieldCode="AU" term="%22Minnema+MC%22">Minnema MC</searchLink>; UMC Utrecht Cancer Center, MS Hematologie, University Medical Center Utrecht, on behalf of HOVON/LLPC, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wierda+WG%22">Wierda WG</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22DeAngelo+DJ%22">DeAngelo DJ</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stiff+P%22">Stiff P</searchLink>; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.<br /><searchLink fieldCode="AU" term="%22Jeyakumar+D%22">Jeyakumar D</searchLink>; University of California Irvine Medical Center, Orange, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mao+D%22">Mao D</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Adhikary+S%22">Adhikary S</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+L%22">Zhou L</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hadjivassileva+T%22">Hadjivassileva T</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Damico+Khalid+R%22">Damico Khalid R</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ghobadi+A%22">Ghobadi A</searchLink>; Washington University School of Medicine, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Oluwole+OO%22">Oluwole OO</searchLink>; Vanderbilt University Cancer Center, Nashville, TN, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2025 May; Vol. 39 (5), pp. 1058-1068. <i>Date of Electronic Publication: </i>2025 Mar 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40108332 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-025-02532-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1058 Titles: – TitleFull: Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shah BD – PersonEntity: Name: NameFull: Cassaday RD – PersonEntity: Name: NameFull: Park JH – PersonEntity: Name: NameFull: Houot R – PersonEntity: Name: NameFull: Logan AC – PersonEntity: Name: NameFull: Boissel N – PersonEntity: Name: NameFull: Leguay T – PersonEntity: Name: NameFull: Bishop MR – PersonEntity: Name: NameFull: Topp MS – PersonEntity: Name: NameFull: O'Dwyer KM – PersonEntity: Name: NameFull: Tzachanis D – PersonEntity: Name: NameFull: Arellano ML – PersonEntity: Name: NameFull: Lin Y – PersonEntity: Name: NameFull: Baer MR – PersonEntity: Name: NameFull: Schiller GJ – PersonEntity: Name: NameFull: Subklewe M – PersonEntity: Name: NameFull: Abedi M – PersonEntity: Name: NameFull: Minnema MC – PersonEntity: Name: NameFull: Wierda WG – PersonEntity: Name: NameFull: DeAngelo DJ – PersonEntity: Name: NameFull: Stiff P – PersonEntity: Name: NameFull: Jeyakumar D – PersonEntity: Name: NameFull: Mao D – PersonEntity: Name: NameFull: Adhikary S – PersonEntity: Name: NameFull: Zhou L – PersonEntity: Name: NameFull: Hadjivassileva T – PersonEntity: Name: NameFull: Damico Khalid R – PersonEntity: Name: NameFull: Ghobadi A – PersonEntity: Name: NameFull: Oluwole OO IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2025 May Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 39 – Type: issue Value: 5 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |
